The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bullock Lawrence E since year 2005.
The trader's CIK number is 1206868.
At the time of this reporting, Bullock Lawrence E is the Chief Financial Officer of Applied Genetic Technologies Corp .
(stock ticker symbol AGTC).
See this page for all insider trading activities at Applied Genetic Technologies Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-09-19||AGTC||Applied Genetic Technologies Corp||Buy||10,000||8.75||87,500|
|2012-03-20||BMTI||Biomimetic Therapeutics, Inc.||Buy||17,670||2.20||38,874|
|2012-03-19||BMTI||Biomimetic Therapeutics, Inc.||Buy||2,330||2.20||5,126|
|2010-12-03||BMTI||Biomimetic Therapeutics, Inc.||Option Ex||37,500||3.63||136,125|
|2009-04-01||BMTI||Biomimetic Therapeutics, Inc.||Buy||6,000||6.79||40,728|
|2008-03-28||BMTI||Biomimetic Therapeutics, Inc.||Buy||10,000||9.00||90,000|
|2006-05-12||BMTI||Biomimetic Therapeutics, Inc.||Buy||10,000||8.00||80,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bullock Lawrence E (Chief Financial Officer of Applied Genetic Technologies Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.